课题基金 / 基金详情

The relationship between epidermal growth factor receptor and hedgehog signaling

The relationship between epidermal growth factor receptor and hedgehog signaling
表皮生长因子受体与hedgehog信号传导的关系
批准号:
8850011
负责人:
Robert B Rebhun
金额:
$13.1万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-15 至 2016-05-31

项目摘要

项目成果

Robert B Rebhun的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):据估计,美国将有超过14万人被诊断患有结肠癌和直肠癌,2010年将有大约51,000人死于这种疾病。大多数结肠癌相关死亡可归因于转移。因此,更好地了解转移过程可能会导致预后和治疗的进步。
英文摘要
DESCRIPTION (provided by applicant): It is estimated that over 140,000 people in the United States will be diagnosed with cancer of the colon and rectum and approximately 51,000 deaths will occur from this disease in 2010. The majority of colon cancer-related deaths can be attributed to metastasis. Therefore, a better understanding of the metastatic process may lead to prognostic and therapeutic advancements. Epidermal growth factor receptor (EGF-R) and Hedgehog (Hh) signaling pathways are independently known to contribute to the development or progression of many cancers including malignancies of the skin, brain, lung, breast, prostate, pancreas, ovary, and colon. Several studies now support the notion that bi- directional cross-talk between Hh and EGF-R can dramatically alter the cellular effects of either pathway alone. However, the implication of these complex interactions in regard to the development, progression, prognosis, and treatment of cancer remain largely unexplored. The goal of this research plan is to determine the contribution of EGF-R and Hh signaling interactions to the progression and metastasis of human colon cancer cells. The specific aims are to 1) Determine the effects of EGF-R on Hh mediated colon cancer cell signaling, growth, and survival, and to 2) Determine how EGF-R and Hh signaling modulates growth, survival, and spontaneous metastasis of human colon cancer cells growing orthotopically in mice. The K01 award would support Dr. Rebhun's career development and will further prepare him for an independent research career in comparative and translational cancer research. Dr. Rebhun is a board certified clinical veterinary oncologist (DVM, Diplomate ACVIM-Oncology) and is a dual-trained clinician/scientist with a Ph.D. degree in cancer biology. Five years of mentored support is requested.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer.
与食品和药物管理局相关的中性粒细胞减少症的频率和严重程度在患有癌症的狗中批准和复合的配方。
DOI: 10.1111/jvim.13805
发表时间: 2016-01
期刊: Journal of veterinary internal medicine
影响因子: 2.6
作者: [Burton JH, Stanley SD, Knych HK, Rodriguez CO, Skorupski KA, Rebhun RB]
通讯作者: Rebhun RB
DOI: 10.1371/journal.pone.0096593
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Shahi MH, Holt R, Rebhun RB]
通讯作者: Rebhun RB
Management of an invasive and metastatic Sertoli cell tumor with associated myelotoxicosis in a dog.
治疗狗的侵袭性和转移性支持细胞肿瘤并伴有相关的骨髓毒症。
DOI: --
发表时间: 2016
期刊: The Canadian veterinary journal = La revue veterinaire canadienne
影响因子: --
作者: [Withers,SitaS, Lawson,CorinneM, Burton,AndrewG, Rebhun,RobertB, Steffey,MicheleA]
通讯作者: Steffey,MicheleA
Evaluation of optimal water fluoridation on the incidence and skeletal distribution of naturally arising osteosarcoma in pet dogs.
最佳水氟化对宠物狗自然发生的骨肉瘤的发病率和骨骼分布的评估。
DOI: 10.1111/vco.12188
发表时间: 2017
期刊: Veterinary and comparative oncology
影响因子: 2.1
作者: [Rebhun,RB, Kass,PH, Kent,MS, Watson,KD, Withers,SS, Culp,WTN, King,AM]
通讯作者: King,AM
共 9 条
    Clinical, molecular, and immune characterization of naturally occurring osteosarcoma in dogs
    • 批准号:
      10717426
    • 项目类别:
    • 资助金额:
      $58.46万
    • 财政年份:
      2023
    • 负责人:
      Robert B Rebhun
    • 依托单位:
    The relationship between epidermal growth factor receptor and hedgehog signaling
    The relationship between epidermal growth factor receptor and hedgehog signaling
    The relationship between epidermal growth factor receptor and hedgehog signaling
    海外基金